Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

OmniVision Technologies, Inc. (OVTI), Sony Corporation (ADR) (SNE): Take a Picture of These Great Stocks

If you’ve ever taken an iPhone picture—or read about someone that has—you’ve used a camera that is comprised of parts from these three big companies: OmniVision Technologies, Inc. (NASDAQ: OVTI), Sony Corporation (ADR) (NYSE:SNE), and Larchan PrecisionWith global cellphone sales topping 1.75 billion units in 2012, and with Apple Inc. (NASDAQ:AAPL) and Samsung together making up 52% of that number, companies like Omnivision, Sony Corporation (ADR) (NYSE:SNE), and Larchan Precision can rest assured there will be plenty more market share to capture.

OmniVision Technologies, Inc. (NASDAQ: OVTI)

OmniVision Technologies, Inc. (NASDAQ:OVTI)

This company is the provider of the front-facing camera on the iPhone. OmniVision Technologies, Inc. (NASDAQ:OVTI) designs, develops, and markets semiconductor image-sensor devices worldwide, mainly through its “CameraChip” image sensors. This particular image sensor is a solution for various imaging functions in a smartphone, such as image capture, image processing, signal conversion and output of images and video.

Financial Snapshot

Over the past five fiscal years, ending FY2013 on April 30, 2013, OmniVision Technologies, Inc. (NASDAQ:OVTI) has doubled its gross revenue from $799 million to $1.4 billion. In that same timeframe, it has kept its average gross profit margin above 25%. Cash flow suffered a bit in FY2013 due to a -$163 million change in inventories, which bled $60.6 million in cash off of the balance sheet. That being said, comparing cash to debt, it has $172 million in net cash, which amounts to $3.18 per share.


Competition in the cellphone and smartphone market will continue to increase, as the Andriod, iOS, and Research in Motion operating systems joust for hard-to-come-by market share. Because of this, OmniVision Technologies, Inc. (NASDAQ:OVTI) will be called upon to further innovate alongside one or more of these operating systems to satisfy the demands from both the manufacturers and consumers.

Analyst consensus estimates have total revenue climbing to $1.65 billion in FY2015, giving shareholders a forward EPS of $1.85. With these numbers, OmniVision Technologies, Inc. (NASDAQ:OVTI) shares are only trading at 9 times 2015 expected earnings. If we were to price the stock at the forward earnings multiplier of the S&P 500 (14.85 times forward earnings), we can put a price tag of $27.50 on this stock. This price target represents a 63% premium over July 24, 2013 closing price for the stock.

Sony Corporation (ADR) (NYSE:SNE)

Sony Corporation (ADR) (NYSE:SNE) is a multibillion-dollar global electronic equipment, instrument, and device developer and manufacturer. It wasn’t until 2011 where a company, IHS iSuppli, took apart the camera aperture in the phone in an attempt to find whom the OEM of the camera was. What they found was OmniVision Technologies, Inc. (NASDAQ:OVTI)’s technology, coupled with Sony Corporation (ADR) (NYSE:SNE)’s imaging sensor, as the backbone behind the camera lenses.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.